Metabolism News and Research

Latest Metabolism News and Research

Potency and dosage of statins linked to diagnosis of osteoporosis

A team of researchers of MedUni Vienna working with the endocrinologists and gender physicians Michael Leutner and Alexandra Kautzky-Willer as well the division for complex statistical systems with Peter Klimek and Caspar Matzhold in cooperation with Complexity Science Hub Vienna were able to demonstrate for the first time a connection between the potency and dosage of statins with a diagnosis of osteoporosis, based on several million data sets.

30 Sep 2019

Carnegie biologists discover possible therapeutic target for slow healing of aged muscles

An age-related decline in recovery from muscle injury can be traced to a protein that suppresses the special ability of muscle stem cells to build new muscles, according to work from a team of current and former Carnegie biologists led by Chen-Ming Fan and published in Nature Metabolism.

30 Sep 2019

Scientists solve mysterious case of auto brewery syndrome

Researchers have made an important discovery that explains the confusing case of a man who had a history of becoming intoxicated without actually drinking alcohol.

30 Sep 2019

A new method to distinguish benign and cancerous skin moles

A new study has reported a cost-effective, more accurate, and less invasive way to diagnose cancerous melanoma cells in skin tumors.

30 Sep 2019

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

30 Sep 2019

Higher dosage of statins can increase risk of osteoporosis, shows study

At low doses, statins could protect against bone resorption. But the higher the dosage of cholesterol-lowering drugs, the greater the probability of osteoporosis, an analysis of millions of patient data by the Complexity Science Hub Vienna shows.

30 Sep 2019

Lipid produced in response to cold helps reduce blood sugar

Researchers based in Brazil, the United States and Germany have discovered that 12-HEPE, a lipid produced in response to cold by brown adipose tissue in the human body, helps reduce blood sugar. The results of their experiments with mice pave the way for new treatments for diabetes.

27 Sep 2019

Study uncovers molecule linking weight gain to gut bacteria

UT Southwestern researchers have found a key driver of the crosstalk that helps synchronize the absorption of nutrients in the gut with the rhythms of the Earth's day-night light cycle.

27 Sep 2019

Anxiety-related behavior associated with disturbances in the cells' powerhouses

The powerhouse of the cell, the mitochondria, provides energy for cellular functions. But those activities can become disturbed when chronic stress leads to anxiety symptoms in mice and humans.

26 Sep 2019

Mount Sinai researchers identify elemental signatures in baby teeth unique to ADHD and autism

Mount Sinai researchers have identified elemental signatures in baby teeth that are unique to attention-deficit/hyperactivity disorder, autism spectrum disorder, and cases when both neurodevelopment conditions are present, which suggests that the metabolic regulation of nutrients and toxins play a role in these diseases, according to a study published in Translational Psychiatry in September.

26 Sep 2019

New discovery sheds light on how pancreatic cancer fuels its growth

A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work - and for whom they will fail.

26 Sep 2019

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

There's no question that as body weight increases, so too does blood pressure. Now, in a study of mice, Johns Hopkins researchers have revealed exactly which molecules are likely responsible for the link between obesity and blood pressure.

From Johns Hopkins Medicine 26 Sep 2019

Researchers identify novel genetic variants linked to plasma lipid levels and cardiovascular risk

An international research team has identified several novel genetic variants associated with plasma levels of lipid species and cardiovascular disease risk in humans.

26 Sep 2019

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Like catching two fish with one worm, treating two problems with a single drug is efficient, but exceedingly difficult.

25 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

AGS patients more likely to suffer from sexual dysfunction, shows study

AdrenoGenital Syndrome (AGS) encompasses a group of inherited metabolic disorders caused by a disruption in steroid hormone production in the adrenal cortex.

25 Sep 2019

Study on gene mutations may lead to better diagnosis and treatment for cancer

When a cell divides into two daughter cells, it must replicate its DNA according to a very specific scenario. In the presence of some disruptive elements, however, cancer cells are unable to perform this operation optimally; replication then takes place more slowly and less efficiently.

25 Sep 2019

MR Solutions’ new liquid helium-free PET-MR system to be displayed at WMIC

MR Solutions’ latest liquid helium free PET-MR preclinical imaging system for the molecular research community was the subject of talks and papers on simultaneous PET-MR imaging at the World Molecular Imaging Congress held in Montreal in September.

From MR Solutions 25 Sep 2019

Space-based investigation helps address challenges involved in learning more about the human brain

Researchers studying neurological diseases face several daunting challenges. For one thing, these conditions may take years or even decades to develop.

25 Sep 2019

Metabolism News and Research

Latest Metabolism News and Research

Potency and dosage of statins linked to diagnosis of osteoporosis

Carnegie biologists discover possible therapeutic target for slow healing of aged muscles

Scientists solve mysterious case of auto brewery syndrome

A new method to distinguish benign and cancerous skin moles

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Higher dosage of statins can increase risk of osteoporosis, shows study

Lipid produced in response to cold helps reduce blood sugar

Study uncovers molecule linking weight gain to gut bacteria

Anxiety-related behavior associated with disturbances in the cells' powerhouses

Mount Sinai researchers identify elemental signatures in baby teeth unique to ADHD and autism

New discovery sheds light on how pancreatic cancer fuels its growth

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Researchers identify novel genetic variants linked to plasma lipid levels and cardiovascular risk

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

UCLA researchers identify new drug delivery pathway to stop tumor growth

AGS patients more likely to suffer from sexual dysfunction, shows study

Study on gene mutations may lead to better diagnosis and treatment for cancer

MR Solutions’ new liquid helium-free PET-MR system to be displayed at WMIC

Space-based investigation helps address challenges involved in learning more about the human brain

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy